Influence of different radioprotective compounds on radiotolerance and cell cycle distribution of human progenitor cells of granulocytopoiesis in vitro

British Journal of Haematology

Volumn 119, Issue 1, 2002, Pages 244-254

  Klingler, Werner ^a   Kreja, Ludwika ^a   Nothdurft, Wilhelm ^a   Selig, Christoph ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

CD34+ cells; Cell cycle; GM CFC; Human bone marrow; Radioprotection

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; ACETYLCYSTEINE; AGAR; AMIFOSTINE; CD34 ANTIGEN; DILTIAZEM; FICOLL; GLYCOPOLYSACCHARIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLANT EXTRACT; POLYSACCHARIDE; RADIOPROTECTIVE AGENT; TEMPOL; THIOPENTAL; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CELL ASSAY; CELL CLONING; CELL CYCLE; CELL CYCLE S PHASE; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; CRYOPRESERVATION; DRUG MECHANISM; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VIVO STUDY; INCUBATION TIME; IRRADIATION; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; SPIRULINA PLATENSIS; STEM CELL; TIME;

ANTIGENS, CD34; CELL CYCLE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS;

EID: 0036400231     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03795.x     Document Type: Article

References (56)

1. Abt, G., Vaghef, H., Gebhart, E., Dahlgren, C.V. & Hellman, B. (1997) The role of N-acetylcysteine as a putative radioprotective agent on X-ray-induced DNA damage as evaluated by alkaline single-cell gel electrophoresis. Mutation Research, 384, 55-64.
2. Almaas, R., Saugstad, O.D., Pleasure, D. & Rootwelt, T. (2000) Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons. Anesthesiology, 92, 764-774.
3. Baier, J.E., Neumann, H.A., Moeller, T., Kissler, M., Borchardt, D. & Ricken, D. (1996) Radiation protection through cytokine release by N-acetylcysteine. Strahlentherapie und Onkologie, 172, 91-98.
4. Blank, L.E., Haveman, J. & van Zandwijk, N. (1987) The radio-protective effect of N-acetylcysteine in thorax irradiation of mice. Radiotherapy and Oncology, 10, 67-69.
5. Broxmeyer, H.E., Galbraith, P.R. & Baker, F.L. (1976) Relationship of colony-stimulating activity to apparent kill of human colony-forming cells by irradiation and hydroxyurea. Blood, 47, 403-411.
6. Calabro-Jones, P.M., Aguilera, J.A., Ward, J.F., Smoluk, G.D. & Fahey, R.C. (1988) Uptake of WR2721 derivates by cells in culture: Identification of the transported form of the drug. Cancer Research, 48, 3634-3640.
7. Calabro-Jones, P.M., Aguilera, J.A., Ward, J.F. & Fahey, R.C. (1998) The limits to radioprotection of Chinese hamster V79 cells by WR1065 under aerobic conditions. Radiation Research, 149, 550-559.
8. Capizzi, R.L. (1999) The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Seminars in Oncology, 26, 3-21.
9. Capizzi, R.L. & Oster, W. (2000) Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. International Journal of Hematology, 72, 425-435.
10. Clark, L.S., Albertini, R.J. & Nicklas, J.A. (1997) The aminothiol WR-1065 protects T lymphocytes from ionizing radiation-induced deletions of the HPRT gene. Cancer Epidemiology, Biomarkers and Prevention, 6, 1033-1037.
11. Floersheim, G.L. (1993) Radioprotective effects of calcium antagonists used alone or in combination with other types of radioprotectors. Radiation Research, 133, 80-87.
12. Hahn, S.M., Wilson, L., Krishna, C.M., Liebmann, J., DeGraff, W., Gamson, J., Samuni, A., Venzon, D. & Mitchell, J.B. (1992) Identification of nitroxide radioprotectors. Radiation Research, 132, 87-93.
13. Hahn, S.M., Krishna, C.M., Samuni, A., DeGraff, W., Cuscela, D.O., Johnstone, P. & Mitchell, J.B. (1994) Potential use of nitroxides in radiation oncology. Cancer Research, 54, 2006s-2010s.
14. Hahn, S.M., Lepinski, D.L., DeLuca, A.M., Mitchell, J.B. & Pellmar, T.C. (1995) Neurophysiological consequences of nitroxide antioxidants. Canadian Journal of Physiology and Pharmacology, 73, 399-403.
15. Hahn, S.M., Sullivan, F.J., DeLuca, A.M., Krishna, C.M., Wersto, N., Venzon, D., Russo, A. & Mitchell, J.B. (1997) Evaluation of tempol radioprotection in a murine tumor model. Free Radical Biology and Medicine, 22, 1211-1216.
16. Hahn, S.M., DeLuca, A.M., Coffin, D., Krishna, C.M. & Mitchell, J.B. (1998) In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. International Journal of Radiation Oncology Biology Physics, 42, 839-842.
17. Hahn, S.M., Krishna, M.C., DeLuca, A.M., Coffin, D. & Mitchell, J.B. (2000) Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radical Biology and Medicine, 28, 953-958.
18. Johnstone, P.A., DeGraff, W.G. & Mitchell, J.B. (1995) Protection from radiation-induced chromosomal aberrations by the nitroxide Tempol. Cancer, 75, 2323-2327.
19. Kimler, B.F., Park, C.H., Yakar, D. & Mies, R.M. (1985) Radiation response of human normal and leukemic hemopoietic cells assayed by in vitro colony formation. International Journal of Radiation Oncology Biology Physics, 11, 809-816.
20. Kligerman, M.M., Glover, D.J., Turrisi, A.T., Norfleet, A.L., Yuhas, J.M., Coia, L.R., Simone, C., Glick, J.H. & Goodman, R.L. (1984) Toxicity of WR-2721 administered in single and multiple doses. International Journal of Radiation Oncology Biology Physics, 10, 1773-1776.
21. Lemoli, R.M., Fortuna, A., Fogli, M., Gherlinzoni, F., Rosti, G., Catani, L., Gozzetti, A., Miggiano, M.C. & Tura, S. (1995) Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Experimental Hematology, 23, 1520-1526.
22. Lemoli, R.M., Tafuri, A., Fortuna, A., Petrucci, M.T., Ricciardi, M.R., Catani, L., Rondelli, D., Fogli, M., Leopardi, G., Ariola, C. & Tura, S. (1997) Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood, 89, 1189-1196.
23. Liebmann, J., DeLuca, A.M., Epstein, A., Steinberg, S.M., Morstyn, G. & Mitchell, J.B. (1994) Protection from lethal irradiation by the combination of stem cell factor and tempol. Radiation Research, 137, 400-404.
24. List, A.F., Heaton, R., Glinsman-Gibson, B. & Capizzii, R.L. (1998) Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors. Leukemia, 12, 1596-1602.
25. Maasilta, P., Holsti, L.R., Blomqvist, P., Kivisaari, L. & Mattson, K. (1992) N-acetylcysteine in combination with radiotherapy in the treatment of non-small cell lung cancer: a feasibility study. Radiotherapy and Oncology, 25, 192-195.
26. Mauch, P., Constine, L., Greenberger, J., Knospe, W., Sullivan, J., Liesveld, J.L. & Deeg, H.J. (1995) Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology Biology Physics, 31, 1319-1339.
27. Moore, M.A. & Shapiro, F. (1994) Regulation and function of hematopoietic stem cells. Current Opinions in Hematology, 1, 180-186.
28. Mori, T., Watanabe, M., Horikawa, M., Nikaido, P., Kimura, H., Aoyama, T. & Sugahara, T. (1983) WR2721, its derivatives and their radioprotective effects on mammalian cells in culture. International Journal of Radiation Biology and Related Studies in Physical Chemistry Medicine, 44, 41-53.
29. Murley, J.S., Constantinou, A., Kamath, N.S. & Grdina, D.J. (1997) WR1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Proliferation, 30, 283-294.
30. Noel, F. & Tofilon, P.J. (1998) Astrocytes protect against X-ray-induced neuronal toxicity in vitro. Neuroreport, 9, 1133-1137.
31. Nothdurft, W. (1991) Bone marrow. In: Radiopathology of Organs and Tissues Medical Radiology - Diagnostic Imaging and Radiation Oncology (ed. by E. Scherer, C. Streffer & K.R. Trott), pp. 113-169. Springer, Berlin.
32. Nothdurft, W., Selig, C., Fliedner, T.M., Hintz-Obertreis, P., Kreja, L., Krumwieh, D., Kurrle, R., Weiler, F.R. & Weinsheimer, W. (1992a) Haematological effects of rhGM-CSF in dogs exposed to total-body irradiation with a dose of 2.4 Gy. International Journal of Radiation Oncology Biology Physics, 61, 519-531.
33. Nothdurft, W., Baltschukat, K. & Selig, C. (1992b) Differences in radiation response between cells in S-phase and non-S-phase cells of the granulocyte/macrophage progenitor (GM-CFC) compartment. International Journal of Radiation Oncology Biology Physics, 23, 345-351.
34. Pierelli, L., Scambia, G., Fattorossi, A., Bonanno, G., Battaglia, A., Perillo, A., Menichella, G., Panici, P.B., Leone, G. & Mancuso, S. (1998) In vitro effect of aminofostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue. British Journal of Cancer, 78, 1024-1029.
35. Pollice, A.A., McCoy, J.P., Shackney, S.E., Smith, C.A., Agarwal, J., Burholt, D.R., Janocko, L.E., Hornicek, F.J., Singh, S.G. & Hartsock, R.J. (1992) Sequential paraformaldehyde and metha-nol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry, 13, 432-444.
36. Qishen, P., Baojiang, G. & Kolman, A. (1989) Radioprotective effect of extract from Spirulina platensis in mouse bone marrow cells studied by using the micronucleus test. Toxicology Letters, 48, 165-169.
37. Ramnath, N., LoRusso, P., Simon, M. & Martino, S. (1997) Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer. American Journal of Clinical Oncology, 20, 368-372.
38. Rubin, D.B., Drab, E.A., Kang, H.J., Baumann, F.E. & Blazek, E.R. (1996) WR-1065 and radioprotection of vascular endothelial cells. I. Cell proliferation, DNA synthesis and damage. Radiation Research, 145, 210-216.
39. Schuchter, L.M. (1996) Guidelines for the administration of amifostine. Seminars in Oncology, 23, 40-43.
40. Selig, C., Nothdurft, W. & Fliedner, T.M. (1993) Radioprotective effect of N-acetylcysteine on granulocyte/macrophage colony-forming cells of human bone marrow. Journal of Cancer Research and Clinical Oncology, 119, 346-349.
41. Selig, C., Kreja, L., Mueller, H., Seifried, E. & Nothdurft, W. (1994) Hematological effects of recombinant human interleukin-6 in dogs exposed to a total-body radiation dose of 2.4 Gy. Experimental Hematology, 22, 551-558.
42. Sigdestad, C.P., Guilford, W., Perrin, J. & Grdina, D.J. (1988) Cell cycle redistribution of cultured cells after treatment with chemical radioprotectors. Cell Tissue Kinetics, 21, 193-200.
43. Sminia, P., van der Kracht, A.H., Frederiks, W.M. & Jansen, W. (1996) Hyperthermia, radiation carcinogenesis and the protective potential of vitamin A and N-acetylcysteine. Journal of Cancer Research and Clinical Oncology, 122, 343-350.
44. Snyder, R.D. & Grdina, D.J. (2000) Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II. Cancer Research, 60, 1186-1188.
45. Solen, G. (1993) Radioprotective effect of N-acetylcysteine in vitro using the induction of DNA breaks as end-point. International Journal of Radiation Biology, 64, 359-366.
46. Spotheim-Maurizot, M., Garnier, F., Kieda, C., Sabattier, R. & Charlier, M. (1993) N-acetylcysteine and captopril protect DNA and cells against radiolysis by fast neutrons. Radiation and Environmental Biophysics, 32, 337-343.
47. Steenvoorden, D.P. & Beijersburgen van Henegouwen, G.M. (1998) Glutathione synthesis is not involved in protection by N-acetylcysteine against UVB-induced systemic immunosuppression in mice. Photochemistry and Photobiology, 68, 97-100.
48. Tannehill, S.P., Mehta, M.P., Larson, M., Storer, B., Pellet, J., Kinsella, T.J. & Schiller, J.H. (1997) Effect of aminofostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial. Journal of Clinical Oncology, 15, 2850-2857.
49. Tarbell, N.J., Rosenblatt, M., Amato, D.A. & Hellman, S. (1986) The effect of N-acetylcysteine inhalation on the tolerance to thoracic radiation in mice. Radiotherapy and Oncology, 7, 77-80.
50. Thierry, D., Gourmelon, P., Parmentier, C. & Nenot, J.C. (1995) Hematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia. International Journal of Radiation Biology, 67, 103-117.
51. Traycoff, C.M., Abboud, M.R., Laver, J., Clapp, D.W. & Srour, E.F. (1994) Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Experimental Hematology, 22, 1264-1272.
52. Verhey, L.J. & Sedlacek, R. (1983) Determination of the radio-protective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin. Radiation Research, 93, 175-183.
53. Warters, R.L., Roberts, J.C., Wilmore, B.H. & Kelley, L.L. (1997) Modulation of radiation-induced apoptosis by thiolamines. International Journal of Radiation Biology, 72, 439-448.
54. Wasserman, T.H. (1994) Radiotherapeutic studies with Amifostine (Ethyol). Seminars in Oncology, 21, 21-25.
55. Watson, R.W., Rotstein, O.D., Jimenez, M., Parodo, J. & Marshall, J.C. (1997) Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils. Blood, 89, 4175-4181.
56. Ziment, I. (1988) Acetylcysteine: a drug that is much more than a mucokinetic. Biomedicine and Pharmacotherapy, 42, 513-519.